Haploinsufficiency of the Myc regulator Mtbp extends survival and delays tumor development in aging mice

Brian C. Grieb,Kelli Boyd,Ramkrishna Mitra,Christine M. Eischen
DOI: https://doi.org/10.18632/aging.101092
2016-10-30
Aging
Abstract:Alterations of specific genes can modulate aging. Myc, a transcription factor that regulates the expression of many genes involved in critical cellular functions was shown to have a role in controlling longevity. Decreased expression of Myc inhibited many of the deleterious effects of aging and increased lifespan in mice. Without altering Myc expression, reduced levels of Mtbp, a recently identified regulator of Myc, limit Myc transcriptional activity and proliferation, while increased levels promote Myc-mediated effects. To determine the contribution of Mtbp to the effects of Myc on aging, we studied a large cohort of <i>Mtbp</i> heterozygous mice and littermate matched wild-type controls. Mtbp haploinsufficiency significantly increased longevity and maximal survival in mice. Reduced levels of Mtbp did not alter locomotor activity, litter size, or body size, but <i>Mtbp</i> heterozygous mice did exhibit elevated markers of metabolism, particularly in the liver. <i>Mtbp</i><sup>+/-</sup> mice also had a significant delay in spontaneous cancer development, which was most prominent in the hematopoietic system, and an altered tumor spectrum compared to <i>Mtbp<sup>+/+</sup></i> mice. Therefore, the data suggest Mtbp is a regulator of longevity in mice that mimics some, but not all, of the properties of Myc in aging.
What problem does this paper attempt to address?